Ole Kirk

Ole Kirk is a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in infection medicine within internal medicine. His research focuses on HIV/AIDS, tuberculosis, and cardiovascular complications in these patient populations, with recent expansion into cardiac effects of viral infections including SARS-CoV-2.

Dr. Kirk's primary research interests include:

• HIV treatment and management strategies
• Tuberculosis risk in HIV-positive individuals
• Cardiovascular disease in people living with HIV
• Metabolic effects of antiretroviral therapy
• Long-term outcomes of HIV infection
• Cardiac manifestations of viral infections

His recent scholarly output demonstrates a strong focus on barriers to HIV care retention, cardiovascular risk prediction in HIV patients, and cardiac complications during the pandemic. Dr. Kirk is a key contributor to major international studies including the RESPOND cohort study examining long-term HIV outcomes and the ECHOVID-19 study investigating cardiac effects of SARS-CoV-2 variants in the Danish population.

With 173 research outputs including 164 journal articles, Dr. Kirk's work has gained significant attention across academic and public spheres, with multiple publications highlighted on social media platforms including X, Facebook, and Bluesky, and attracting substantial readership on academic networking sites like Mendeley.

Based at Blegdamsvej 9 and Blegdamsvej 3 in Copenhagen, Dr. Kirk maintains active research collaborations across Europe and continues to publish cutting-edge research as evidenced by multiple 2025 publications.